dronabinol has been researched along with Brain Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akpunonu, P; Baum, RA; Davidson, B; Ellison, R; Gerona, R; Reckers, A; Riley, M; Trecki, J | 1 |
| Bernal-Chico, A; Manterola, A; Mato, S; Matute, C; Tepavcevic, V; Utrilla, C | 1 |
| Hayes, MW; Kunchok, A; Spring, PJ | 1 |
| Lichtman, AH; Mechoulam, R | 1 |
| Cabral, GA; Marciano-Cabral, F | 1 |
| Hader, W; Yang, C; Zhang, X | 1 |
| Bradley, SG; Cabral, G; Ferguson, T; Marciano-Cabral, F | 1 |
| Heath, RG; Meyers, WA | 1 |
1 review(s) available for dronabinol and Brain Diseases
| Article | Year |
|---|---|
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells.
Topics: Animals; Brain Diseases; Cannabinoids; Dronabinol; Endocannabinoids; Humans; Microglia; Receptors, Cannabinoid | 2023 |
7 other study(ies) available for dronabinol and Brain Diseases
| Article | Year |
|---|---|
Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies.
Topics: Brain Diseases; Cannabinoids; Child; Child, Preschool; Dronabinol; Eating; Female; Humans | 2021 |
Encephalopathy after chocolate consumption.
Topics: Adult; Australia; Brain Diseases; Cannabinoids; Chocolate; Dronabinol; Economics; Emergency Service, Hospital; Female; Gait Disorders, Neurologic; Humans; Substance Abuse Detection; Vertigo; Vomiting; Young Adult | 2018 |
Neuroscience. Stout guards of the central nervous system.
Topics: Animals; Anticonvulsants; Arachidonic Acids; Brain; Brain Diseases; Cannabidiol; Cannabinoid Receptor Modulators; Cannabinoids; Convulsants; Dronabinol; Endocannabinoids; Epilepsy; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glutamic Acid; Glycerides; Humans; Kainic Acid; Mice; Neurons; Neuroprotective Agents; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction | 2003 |
Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae.
Topics: Acanthamoeba; Amebiasis; Amoeba; Animals; Blotting, Western; Brain Diseases; Cannabinoids; Cells, Cultured; Cyclophosphamide; Cytokines; Dose-Response Relationship, Drug; Dronabinol; Female; Immunohistochemistry; Immunosuppressive Agents; Lung Abscess; Mice; Nuclear Proteins; Opportunistic Infections; Psychotropic Drugs; RNA, Messenger; Transcription Factors | 2004 |
Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite.
Topics: Adrenalectomy; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Axons; Brain Diseases; Cannabinoids; Corpus Callosum; Corticosterone; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Enzyme Inhibitors; Immunohistochemistry; Male; Molsidomine; Morpholines; Peroxynitrous Acid; Pyrazoles; Rats; Rats, Wistar | 2006 |
Delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, exacerbates brain infection by Acanthamoeba.
Topics: Acanthamoeba; Amebiasis; Animals; Antibodies, Protozoan; Brain Diseases; Central Nervous System Protozoal Infections; Cyclophosphamide; Disease Models, Animal; Dronabinol; Female; Humans; Immunocompetence; Immunocompromised Host; Immunosuppressive Agents; Mice | 2001 |
Cannabis sativa: ultrastructural changes in organelles of neurons in brain septal region of monkeys.
Topics: Animals; Brain Diseases; Cannabis; Cell Count; Dronabinol; Endoplasmic Reticulum; Golgi Apparatus; Haplorhini; Macaca mulatta; Mitochondria; Septum Pellucidum | 1979 |